APA (7th ed.) Citation

HF, T., LS, S., BK, A., E, R., J, W., Y, L., . . . L, Q. (2026). Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 81(6), e717. https://doi.org/10.1093/cid/ciaf329

Chicago Style (17th ed.) Citation

HF, Tseng, et al. "Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 81, no. 6 (2026): e717. https://doi.org/10.1093/cid/ciaf329.

MLA (9th ed.) Citation

HF, Tseng, et al. "Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 81, no. 6, 2026, p. e717, https://doi.org/10.1093/cid/ciaf329.